Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 22 of 6351
-
Ebola vaccine trial aims to shield frontline workers in congo
Vaccine CompletedThis Phase 2 study aims to improve preparedness for future Ebola outbreaks by vaccination of a well-known population at risk, ie, a cohort of health care providers (HCP) (such as primary, emergency, and community health care workers) who may be exposed to Ebola in the event of a …
Phase 2 • Sponsor: Universiteit Antwerpen • Aim: Vaccine
Last updated Jul 16, 2026 00:00 UTC
-
Could Weight-Loss surgery slash heart risks in diabetes?
Disease control CompletedThe objective of the analysis was to evaluate the relationship between bariatric surgery and cardiovascular outcomes in obese patients with type 2 diabetes.
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a Blood-Cleansing combo tame deadly lung Flare-Ups?
Disease control Stopped earlyIdiopathic pulmonary fibrosis (IPF) is a fibroproliferative, irreversible disease of unknown cause, occurring mainly in patients older than 50. IPF is a rare but fatal lung disease, with an estimated prevalence of 14 to 28/100000 and a median survival time of 3 years. Acute exace…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a common drug shield children with sickle cell from stroke?
Prevention OngoingThis study will 1) Evaluate the prevalence of elevated (conditional or abnormal) transcranial Doppler (TCD) velocities in a cross-sectional analysis of children with Sickle Cell Anemia (SCA) living in Tanzania; 2) Obtain longitudinal data on TCD velocities in this population; and…
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
Could a lung 'Second Look' system expand the donor pool?
Disease control CompletedThe objective of this study is to evaluate the safety and effectiveness of the Centralized Lung Evaluation System (CLES) in enabling evaluation of potential donor lungs not otherwise used for transplant into subjects with end stage, survival-limiting lung disease in need of lung …
Sponsor: Lung Bioengineering Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can an Immune-Boosting antibody extend life in advanced lung cancer?
Disease control CompletedThis is a multi-center, randomized, double-blind, phase III study to evaluate the efficacy and safety of CS1001 in combination with platinum-containing chemotherapy versus placebo in combination with chemotherapy in first-line treatment-naive subjects with stage IV non-small cell…
Phase 3 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Early Gluten-Free diet or probiotics: a new strategy to prevent celiac disease?
Prevention OngoingThis study aims to investigate the impact of being on a gluten free diet the first three years of life compared to a daily intake of a probiotic supplementation or placebo on the risk of developing celiac disease autoimmunity or celiac disease in genetically susceptible children.…
Sponsor: Lund University • Aim: Prevention
Last updated Sep 09, 2026 16:00 UTC
-
New pill takes aim at 'Undruggable' cancer mutation
Disease control CompletedEvaluate the safety and tolerability of sotorasib in adult subjects with KRAS p.G12C mutant advanced solid tumors. Estimate the maximum tolerated dose (MTD) and/or a recommended phase 2 dose (RP2D) in adult subjects with KRAS p.G12C mutant advanced solid tumors.
Phase 1/2 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
One-Time gene therapy could free hemophilia b patients from frequent infusions
Disease control CompletedThis is an open-label, single-dose, multi-center, multinational trial to demonstrate the efficacy of AMT-061 and to further describe its safety profile. The study drug is identified as AAV5-hFIXco-Padua (AMT- 061). AMT-061 is a recombinant adeno-associated viral vector of seroty…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a new drug combo shield young hearts from transplant complications?
Disease control CompletedThe TEAMMATE Trial will enroll 210 pediatric heart transplant patients from 25 centers at 6 months post-transplant and follow each patient for 2.5 years. Half of the participants will receive everolimus and low-dose tacrolimus and the other half will receive tacrolimus and mycoph…
Phase 3 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a new HIV drug combo better protect pregnant women and their babies?
Disease control CompletedThe purpose of this study was to compare the virologic efficacy and safety of three antiretroviral (ARV) regimens, dolutegravir plus emtricitabine/tenofovir alafenamide, dolutegravir plus emtricitabine/tenofovir disoproxil fumarate, and efavirenz/emtricitabine/tenofovir disoproxi…
Phase 3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
A drug that protects the liver may make stem cell transplants safer for children with sickle cell disease
Cure Recruiting nowThis is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibrotide prophylaxis for high-risk sickle cell or beta thalassemia patients undergoing a familial haploidentical or MUD allogeneic stem cell transplantation with CD…
Phase 2 • Sponsor: New York Medical College • Aim: Cure
Last updated Jul 29, 2026 00:00 UTC
-
New HIV prevention pill shows promise in large trial
Prevention Stopped earlyThe primary objective of this study is to assess the rates of HIV-1 infection in Men (MSM) and transgender women (TGW) who have sex with men and who are administered daily emtricitabine/tenofovir alafenamide (F/TAF) or emtricitabine/tenofovir disoproxil fumarate (F/TDF) with a mi…
Phase 3 • Sponsor: Gilead Sciences • Aim: Prevention
Last updated Sep 09, 2026 16:00 UTC
-
Womb transplants could let infertile women give birth
Disease control OngoingThis study aims to investigate the treatment of absolute uterine infertility (AUI) due to congenital or surgical absence of a uterus or presence of a nonfunctioning uterus. The investigators will follow a model based on a Swedish study to enroll 20 women with functioning ovaries …
Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Designing an HIV vaccine that avoids the Virus's sneaky tactics
Vaccine OngoingThe purpose of this research study is to develop a vaccine against Human immunodeficiency virus (HIV), a disease that causes AIDS in people,. The investigator will be looking at viruses similar to HIV in animals. Since these viruses are very similar to HIV, the blood from humans …
Sponsor: University of Florida • Aim: Vaccine
Last updated Sep 09, 2026 16:00 UTC
-
Massive AML trial aims to find best chemo and transplant protection for younger patients
Disease control Recruiting nowThis open label, multicenter phase II/III study with multiple randomization phases at differents stages of AML treatment (induction, consolidation and HSCT where applicable) is designed to improve OS in younger (18 to 60 year-old) patients, with AML risk-adapted patient strategie…
Phase 2/3 • Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Peanut allergy cure in sight? trial tests tolerance in teens
Cure CompletedThe primary purpose of the protocol is to evaluate the efficacy of a protocol for induction of tolerance to peanut ingestion increasing doses. The secondary purpose is to determine the interest of a prolonged maintenance therapy
Phase 2/3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Cure
Last updated Aug 05, 2026 00:00 UTC
-
Can heated chemotherapy boost survival in stomach cancer?
Disease control CompletedA prospective, opened, multicentric, randomised, phase III trial with two arms: * Arm A: curative gastrectomy with D1-D2 lymph node dissection + HIPEC with oxaliplatin * Arm B: curative gastrectomy with D1-D2 lymph node dissection Main objective: Compare overall 5-year survival…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a targeted drug keep High-Risk breast cancer from returning?
Disease control OngoingA significant number of patients relapse and eventually die, particularly if they were initially diagnosed with large nodes involvement and/or T3/4 diseases. When analyses focus on patients with ER+/Her2-negative breast cancer, with ≥4N+, 30% had relapsed at 5 years, emphasizing …
Phase 3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can the Body's own immune cells beat a recurrent brain tumor?
Cure CompletedImmunotherapy is a specific approach to treating cancer that has shown promise in adult patients for the treatment of melanoma, malignant brain tumors, and other cancers. The study investigators will use the experience they have gained from these studies to try to improve the out…
Phase 2 • Sponsor: University of Florida • Aim: Cure
Last updated Aug 15, 2026 00:00 UTC